These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 22901222

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z, Guo Y.
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC.
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [Abstract] [Full Text] [Related]

  • 8. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W, Jiang WY, Chen WS, Sun W, Fu XN.
    Asian Pac J Cancer Prev; 2013 Sep; 14(6):3613-8. PubMed ID: 23886154
    [Abstract] [Full Text] [Related]

  • 9. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of annexin II expression in non-small cell lung cancer.
    Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC, Liu YF.
    Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
    [Abstract] [Full Text] [Related]

  • 11. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX, Zhou RS, Xu HF, Wang JY, Yuan MH.
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [Abstract] [Full Text] [Related]

  • 12. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
    Wang X, Du Z, Li L, Shi M, Yu Y.
    Int J Clin Exp Pathol; 2015 Apr; 8(9):10644-52. PubMed ID: 26617774
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY.
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [Abstract] [Full Text] [Related]

  • 14. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
    Xu Y, Chen Z, Zhang G, Xi Y, Sun R, Wang X, Wang W, Chai F, Li X.
    Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
    [Abstract] [Full Text] [Related]

  • 15. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [Abstract] [Full Text] [Related]

  • 16. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X, Wang D.
    BMC Cancer; 2016 Nov 10; 16(1):876. PubMed ID: 27832750
    [Abstract] [Full Text] [Related]

  • 17. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
    Hwang J, Kang MH, Yoo YA, Quan YH, Kim HK, Oh SC, Choi YH.
    World J Surg Oncol; 2014 Aug 21; 12():268. PubMed ID: 25141859
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY, Gu X, Wang HR, Liu D, Lv FZ, Li JN.
    Tumour Biol; 2013 Apr 21; 34(2):821-5. PubMed ID: 23229099
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M, Uramoto H, Oka S, Chikaishi Y, Iwanami T, Shimokawa H, So T, Hanagiri T, Tanaka F.
    Clin Lung Cancer; 2012 Mar 21; 13(2):136-42. PubMed ID: 22133293
    [Abstract] [Full Text] [Related]

  • 20. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
    Huang G, Song H, Wang R, Han X, Chen L.
    J Surg Oncol; 2012 Mar 15; 105(4):420-4. PubMed ID: 21780128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.